Leonteq Securities AG’s Amphastar Pharmaceuticals AMPH Stock Holding History

Leonteq Securities AG’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,000	Closed	-$23K	–	1321
2025 Q2	$23K	Hold	1,000	–	–	﹤0.01%	969
2025 Q1	$29K	Hold	1,000	–	–	﹤0.01%	917
2024 Q4	$37.1K	Hold	1,000	–	–	﹤0.01%	877
2024 Q3	$48.5K	Hold	1,000	–	–	﹤0.01%	757
2024 Q2	$40K	Sell	1,000 -200	-17%	-$8.29K	﹤0.01%	802
2024 Q1	$52.7K	Buy	1,200 +200	+20%	+$10.3K	﹤0.01%	763
2023 Q4	$61.9K	Hold	1,000	–	–	﹤0.01%	734
2023 Q3	$46K	Buy	+1,000	New	+$54.6K	﹤0.01%	814

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Leonteq Securities AG's AMPH Position: Q3 2025 in Review

Leonteq Securities AG sold out of Amphastar Pharmaceuticals (AMPH) in Q3 2025, closing a stake of 1,000 shares — an estimated $23K sold.

Leonteq Securities AG first reported a position in AMPH in Q3 2023 and held it in 8 quarters. The position peaked at $61.9K in Q4 2023. 243 funds tracked by Wall St. Rank hold AMPH as of Q3 2025.

Leonteq Securities AG reported no remaining Amphastar Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
Leonteq Securities AG sold 1,000 Amphastar Pharmaceuticals shares in Q3 2025, an estimated $23K.
Leonteq Securities AG first reported a position in Amphastar Pharmaceuticals in Q3 2023 and held it in 8 quarters.
Leonteq Securities AG's Amphastar Pharmaceuticals position peaked at $61.9K in Q4 2023.
243 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2025.

Based on Leonteq Securities AG's 13F filing for Q3 2025, filed 17 Feb 2026.